Dow Down 0.17% Nasdaq Down 0.28%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
45.36 Down 2.72(5.66%) Sep 30, 4:00PM EDT
|After Hours : 45.36 Down 0.00 (0.01%) Sep 30, 4:38PM EDT
Prev Close:48.08
Open:47.74
Bid:40.00 x 100
Ask:N/A
1y Target Est:81.11
Beta:2.19
Earnings Date:Nov 3 - Nov 8 (Est.)
Day's Range:44.89 - 48.16
52wk Range:35.33 - 93.33
Volume:1,176,771
Avg Vol (3m):740,516
Market Cap:1.54B
P/E (ttm):N/A
EPS (ttm):-3.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLVS

Comparison

Symbol% ChgMkt Cap
CLVSDown 5.66%1.54B
IMMUDown 3.12%346.38M
LRUSF 0.00%N/A
THLDDown 3.73%214.31M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):119.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-4.00
Quarterly EPS Est (Sep-14) :-1.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback